Use of recombinant human granulocyte-macrophage colony stimulating factor in an infant with reticular dysgenesis

Mar 1, 1994 | Magazine: European Journal of Pediatrics

Azcona C, Alzina V, Barona P, Sierrasesúmaga L, Villa-Elízaga I.

Abstract
We present the case of a 2-month-old infant with reticular dysgenesis who was treated with recombinant granulocyte-macrophage colony stimulating factor with the aim of stimulating granulopoiesis while awaiting bone marrow transplant.